Pilatus Biosciences is a biotech company in Lausanne, Switzerland, focusing on developing advanced cancer treatments. They specialize in using CD36 and IL-10 to reprogram cancer cell metabolism for more effective immunotherapy. Their research, led by Dr. Ping-Chih Ho, aims to improve cancer treatment by targeting metabolic stress in tumors. Pilatus Biosciences values collaboration, innovation, and making a positive impact on cancer patients' lives.
Website →